C

Cognition Therapeutics, Inc.

33 employees

Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Life Science

Date founded

2007

Funding rounds raised

Total raised

$12M

from 9 investors over 9 rounds

C

Cognition Therapeutics, Inc. raised $3M on October 1, 2016

Investors: Maine Angels and Sofia Fund

C

Cognition Therapeutics, Inc. raised $3.5M on March 31, 2016

Investors: Sofia Fund

C

Cognition Therapeutics, Inc. raised $12M on September 8, 2015

Investors: Dolby Family Ventures, -, Plsg Accelerator Fund, Cowtown Angels, Maine Angels and Golden Seeds

FAQ